VIRAGEN  VRGN TO BEGIN EXPANDED HERPES STUDIES HIALEAH FLA MARCH 16 VIRAGEN INC SAID IT WILL START AN EXPANDED STUDY OF ITS ALPHA INTERFERON TOPICAL OINTMENT FOR THE TREATMENT OF GENITAL HERPES IT SAID IT WILL CONDUCT A PHASE III STUDY OF TWO DIFFERENT DOSAGE FORMS OF THE TREATMENT AND COMPARE IT TO A PLACEBO OR NONMEDICATED SUBSTITUTE IN AT LEAST 154 MEN AND WOMEN VIRAGEN SAID STUDY RESULTS ARE EXPECTED BY OCTOBER 1987 VIRAGEN SAID IT IS PREPARED TO SUBMIT LICENSE APPLICATIONS FOR THE OINTMENT IN ENGLAND CANADA AND WEST GERMANY IN ADDITION TO THE US WHEN THE PHASE III STUDY IS COMPLETED   